| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-31 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.44B | $3.09B | $3.43B |
| YoY Revenue Growth % | +11.3% | -9.8% | — |
| Gross Profit | $403.3M | $388.6M | — |
| Gross Margin % | 11.7% | 12.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.4M | $147.0M | $194.5M |
| Operating Margin % | 0.0% | 4.8% | 5.7% |
| Net Income (GAAP) | -$13.0M | $119.0M | $170.0M |
| EBITDA (Normalized) | $95.6M | $251.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $201.2M | $230.3M | $199.5M |
| Capital Expenditures (CapEx) | $121.2M | $130.4M | — |
| Free Cash Flow (FCF) | $80.0M | $99.9M | $199.5M |
| FCF Margin % | 2.3% | 3.2% | 5.8% |
| Return on Invested Capital (ROIC %) | -0.1% | 12.1% | — |
| Cash & Short-Term Equivalents | $89.8M | $52.0M | — |
| Total Debt (Short + Long Term) | $41.7M | $0 | — |
| Total Stockholders' Equity | $1.12B | $1.01B | — |